Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) shares gapped down before the market opened on Monday . The stock had previously closed at $69.5550, but opened at $65.10. Basilea Pharmaceutica shares last traded at $65.10, with a volume of 11 shares.
Basilea Pharmaceutica Trading Down 5.7%
The company’s 50 day moving average price is $70.23 and its 200 day moving average price is $67.20. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.68 and a current ratio of 5.11.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG is a Swiss biopharmaceutical company headquartered in Basel, specializing in the development and commercialization of innovative treatments for hospital‐treated diseases. The company’s research is focused primarily on anti‐infectives and oncology, with a portfolio that spans both marketed products and early‐ to late‐stage pipeline candidates. Basilea leverages medicinal chemistry expertise to address critical medical needs in fungal infections, bacterial infections and cancer.
Among its lead products is isavuconazole, a broad‐spectrum antifungal agent marketed under the trade name Cresemba.
Featured Stories
- Five stocks we like better than Basilea Pharmaceutica
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
